MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by TheShakAttackon Jul 08, 2020 11:27pm

210 Views

Post# 31243304

RE:Possibility? -- FDA delay waiting on Medmira Production Cap

Good point EtheGreat However, preference will always been given to the stateS with the most cases. We cant expect the production to be ready with 400 million kits to cover both US and Canada and then grant the FDA APPROVAL. There are always some delays and back orders in the beginning which will drive the price of the kit to go higher based on shortage and demand. Thoughts?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario